BioCentury
ARTICLE | Politics & Policy

FDA announces classwide changes for opioids

September 11, 2013 12:54 AM UTC

FDA on Tuesday announced classwide labeling changes and new postmarket study requirements for extended-release and long-acting opioids. The agency said manufacturers must conduct one or more (see BioC...